Biotech

Coherus BioSciences, Inc.

1

Articles

Mentioned

Top Role

Mar 12, 2026

First Mention

Mar 12, 2026

Last Mention

0.61

Relevance Score

Coverage Timeline

March 2026

Biosimilar Adoption Rates: ABP 959’s Market Share Challenge to Soliris After 2025 Data Mentioned

Mar 12, 2026

Biosimilar launches like Coherus’ Udenyca and Amgen’s Mvasi broke the $1 billion annual threshold within three years.